H.R. 2936 · 108th Congress
Prescription Drug Tampering Prevention Act of 2003
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
DeutschSponsor1 cosponsor · 1 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Prescription Drug Tampering Prevention Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act to provide for fines or imprisonment, or both, for an individual for knowingly violating certain provisions by selling or trading adulterated or misbranded prescription drugs.
What it does: CRS summary · Introduced in House · Jul 25, 2003
Prescription Drug Tampering Prevention Act of 2003 - Amends the Federal Food, Drug, and Cosmetic Act to provide for fines or imprisonment, or both, for an individual for knowingly violating certain provisions by selling or trading adulterated or misbranded prescription drugs. Punishes an individual also for buying or trading for a prescription drug while knowing or having reason to know that the drug was knowingly caused to be adulterated or misbranded. States that in either instance an individual shall be fined in accordance with Federal law relating to crimes and criminal procedure, imprisoned for any term of years or for life, or both.
Modifies provisions pertaining to criminal penalties for committing certain prohibited acts involving food, drugs, devices, or cosmetics. Makes a violation punishable by a fine in accordance with Federal law relating to crimes and criminal procedure, imprisonment for not more than one year, or both. (Current law prescribes a fine of up to $1,000 and/or imprisonment for not more than one year). Makes a second violation, or a violation committed with intent to defraud or mislead, punishable by a fine in accordance with Federal law, imprisonment for not more than three years, or both. (Current law prescribes a fine of up to $10,000 and/or imprisonment for not more than three years.) Makes a violation of provisions pertaining to prescription drug marketing punishable by a fine in accordance with Federal law, imprisonment for not more than ten years, or both. (Current law prescribes a fine of up to $250,000 and/or imprisonment for not more than ten years.)
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: Prescription Drug Tampering Prevention Act of 2003
Latest action (Aug 8, 2003): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Jul 25, 2003
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.